跳至主要内容
临床试验/CTRI/2019/07/020345
CTRI/2019/07/020345尚未招募4 期

Effectiveness, tolerability and safety of topical clobetasol with oral hydroxychloroquine versus topical clobetasol with NBUVB phototherapy in unstable vitiligo: Investigator blind, randomized controlled trial.

Bankura Sammilani Medical College0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Age >=18 yrs to <=85 years
  • 2.Extension of preexisting vitiligo lesion with
  • in last one year.
  • 3.Appearance of new lesion with in last one
  • 4.Presence of Koëbner phenomenon during the
  • past 1 year
  • 5.Trichrome or quadrichrome vitiligo
  • 6.No use of any systemic therapy for 4 weeks
  • prior to enrollment in the study;
  • 7.Informed consent obtained
  • 8.Willing for twice weekly treatment with
  • narrow band ultraviolet B phototherapy.

排除标准

  • 1.Childhood vitiligo.
  • 2.Pregnant and lactating women.
  • 3.Patient taking known photosensitizer drugs or
  • immunosuppressive therapy.
  • 4.Concomitant immune defects, heart disease,
  • renal failure, malignancy.
  • 5.Patient having retinopathy.
  • 6.Neurological or psychiatric disorders.
  • 7.History of photosensitivity or photo mediated
  • 8.Participation in any clinical trial within
  • the last 3 months
  • 9.Substance or alcohol abuse.
  • 10.Patient having diabetes mellitus.

研究者

相似试验